Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:GHNYSE:HIMSNASDAQ:OPCHNASDAQ:PGNY On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeGHGuardant Health$42.89+5.5%$42.83$15.81▼$50.89$5.02B1.52.14 million shs1.76 million shsHIMSHims & Hers Health$33.10+5.0%$38.49$11.20▼$72.98$7.35B1.3713.49 million shs17.05 million shsOPCHOption Care Health$32.66+1.3%$30.81$21.39▼$34.85$5.33B1.331.63 million shs2.19 million shsPGNYProgyny$20.36+2.6%$21.58$13.39▼$38.98$1.74B1.411.59 million shs1.61 million shs20 Stocks to Sell NowMarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio?Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceGHGuardant Health+5.54%+9.08%-5.49%+23.39%+125.74%HIMSHims & Hers Health+5.21%-8.08%-28.70%+10.27%+118.94%OPCHOption Care Health+1.30%-3.97%+2.51%+39.04%+0.77%PGNYProgyny+2.62%-2.12%-7.54%+39.36%-44.51%Remove AdsCompare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationGHGuardant Health4.2722 of 5 stars3.52.00.04.43.32.50.6HIMSHims & Hers Health3.3612 of 5 stars3.12.00.00.03.13.31.9OPCHOption Care Health4.2369 of 5 stars2.45.00.04.23.72.50.6PGNYProgyny2.3172 of 5 stars2.22.00.00.02.74.21.3Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceGHGuardant Health 3.00Buy$48.4012.85% UpsideHIMSHims & Hers Health 2.27Hold$37.2312.47% UpsideOPCHOption Care Health 2.75Moderate Buy$33.001.04% UpsidePGNYProgyny 2.31Hold$24.8221.90% UpsideCurrent Analyst Ratings BreakdownLatest PGNY, HIMS, OPCH, and GH Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails3/6/2025GHGuardant HealthMorgan StanleySubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOverweight ➝ Overweight$42.00 ➝ $52.003/6/2025HIMSHims & Hers HealthBank of AmericaSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingUnderperform ➝ Underperform$21.00 ➝ $21.003/6/2025HIMSHims & Hers HealthCitigroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingSell ➝ Sell$27.00 ➝ $27.003/6/2025OPCHOption Care HealthJPMorgan Chase & Co.Subscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOverweight ➝ Overweight$40.00 ➝ $41.002/28/2025PGNYProgynyCanaccord Genuity GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetHold ➝ Hold$17.00 ➝ $23.002/27/2025OPCHOption Care HealthBarrington ResearchSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOutperform ➝ Outperform$33.00 ➝ $38.002/26/2025GHGuardant HealthPiper SandlerSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOverweight ➝ Overweight$34.00 ➝ $50.002/26/2025HIMSHims & Hers HealthTruist FinancialSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetHold ➝ Hold$24.00 ➝ $39.002/25/2025HIMSHims & Hers HealthLeerink PartnersSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetMarket Perform ➝ Market Perform$24.00 ➝ $40.002/25/2025HIMSHims & Hers HealthPiper SandlerSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetNeutral ➝ Neutral$24.00 ➝ $35.002/25/2025HIMSHims & Hers HealthCitigroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetSell ➝ Sell$25.00 ➝ $27.00(Data available from 3/15/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookGHGuardant Health$739.02M7.16N/AN/A$1.34 per share32.01HIMSHims & Hers Health$1.48B4.98N/AN/A$1.61 per share20.56OPCHOption Care Health$5.00B1.08$1.90 per share17.19$8.03 per share4.07PGNYProgyny$1.17B1.49$0.57 per share35.58$5.77 per share3.53Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateGHGuardant Health-$479.45M-$3.56N/AN/AN/A-59.05%-19,157.20%-25.96%5/8/2025 (Estimated)HIMSHims & Hers Health-$23.55M$0.5475.2463.66N/A8.19%10.97%8.29%5/5/2025 (Estimated)OPCHOption Care Health$267.09M$1.2227.4525.922.304.37%15.30%6.57%4/22/2025 (Estimated)PGNYProgyny$62.04M$0.5735.1031.322.395.03%11.36%7.87%5/8/2025 (Estimated)Latest PGNY, HIMS, OPCH, and GH EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails2/24/2025Q4 2024HIMSHims & Hers Health$0.09$0.11+$0.02$0.11$494.56 million$481.14 million2/20/2025Q4 2024GHGuardant Health-$0.75-$0.90-$0.15-$0.90$192.50 million$201.81 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthGHGuardant HealthN/AN/AN/AN/AN/AHIMSHims & Hers HealthN/AN/AN/AN/AN/AOPCHOption Care HealthN/AN/AN/AN/AN/APGNYProgynyN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioGHGuardant HealthN/A6.225.85HIMSHims & Hers HealthN/A2.141.82OPCHOption Care Health0.771.731.32PGNYProgynyN/A2.622.62Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipGHGuardant Health92.60%HIMSHims & Hers Health63.52%OPCHOption Care Health98.05%PGNYProgyny94.93%Insider OwnershipCompanyInsider OwnershipGHGuardant Health5.50%HIMSHims & Hers Health17.71%OPCHOption Care Health0.64%PGNYProgyny12.30%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableGHGuardant Health1,779123.42 million116.76 millionNot OptionableHIMSHims & Hers Health1,046222.17 million179.79 millionOptionableOPCHOption Care Health5,600165.32 million169.09 millionOptionablePGNYProgyny31085.41 million74.68 millionOptionablePGNY, HIMS, OPCH, and GH HeadlinesRecent News About These CompaniesProgyny, Inc. (NASDAQ:PGNY) Shares Sold by Bank of New York Mellon CorpMarch 15 at 3:06 AM | marketbeat.comProgyny launches Parent and Child Well-being OfferingMarch 12 at 12:26 AM | markets.businessinsider.comProgyny, Inc. Launches Comprehensive Parent and Child Well-being Offering to Support Working FamiliesMarch 11, 2025 | quiverquant.comProgyny Expands Family Building Solutions with New Parent and Child Well-being OfferingMarch 11, 2025 | globenewswire.comRiver Road Asset Management LLC Buys Shares of 1,479,944 Progyny, Inc. (NASDAQ:PGNY)March 11, 2025 | marketbeat.comTruist Financial Sticks to Its Hold Rating for Progyny (PGNY)March 10, 2025 | markets.businessinsider.comProgyny, Inc. (NASDAQ:PGNY) Shares Bought by Edgestream Partners L.P.March 9, 2025 | marketbeat.comProgyny, Inc. to Participate in Upcoming Investor ConferencesMarch 7, 2025 | gurufocus.comProgyny, Inc. to Participate in Upcoming Investor ConferencesMarch 7, 2025 | globenewswire.comOppenheimer Asset Management Inc. Sells 76,319 Shares of Progyny, Inc. (NASDAQ:PGNY)March 6, 2025 | marketbeat.comNew York State Common Retirement Fund Has $441,000 Stock Holdings in Progyny, Inc. (NASDAQ:PGNY)March 5, 2025 | marketbeat.comPGNY CEO on "Well-Positioned" Sales Year & Expanding FootprintMarch 3, 2025 | youtube.comHealth Insurance Providers Q4 Earnings: Progyny (NASDAQ:PGNY) Simply the BestMarch 3, 2025 | msn.comExpert Outlook: Progyny Through The Eyes Of 4 AnalystsMarch 2, 2025 | nasdaq.comPrincipal Financial Group Inc. Sells 419,185 Shares of Progyny, Inc. (NASDAQ:PGNY)March 2, 2025 | marketbeat.comProgyny (NASDAQ:PGNY) Shares Gap Up After Analyst UpgradeMarch 1, 2025 | marketbeat.comProgyny (NASDAQ:PGNY) Price Target Raised to $23.00March 1, 2025 | marketbeat.comProgyny price target raised to $34 from $30 at BofAMarch 1, 2025 | markets.businessinsider.comProgyny price target raised to $23 from $17 at CanaccordMarch 1, 2025 | markets.businessinsider.comProgyny projects slower revenue growth after losing AmazonFebruary 28, 2025 | crainsnewyork.comProgyny, Inc. Reports Strong 2024 Earnings with Optimistic OutlookFebruary 28, 2025 | tipranks.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop HeadlinesView All HeadlinesPrice Targets on NVIDIA Rise in Front of EarningsBy Sarah Horvath | February 24, 2025View Price Targets on NVIDIA Rise in Front of EarningsHims & Hers Earnings Could Be a Game Changer—What to Do NowBy Gabriel Osorio-Mazilli | February 18, 2025View Hims & Hers Earnings Could Be a Game Changer—What to Do NowMissed the Hims & Hers Rally? Clover Health Could Be NextBy Gabriel Osorio-Mazilli | March 5, 2025View Missed the Hims & Hers Rally? Clover Health Could Be NextWall Street’s Most Wanted: 2 Highly Shorted Stocks Right NowBy Leo Miller | February 26, 2025View Wall Street’s Most Wanted: 2 Highly Shorted Stocks Right NowHims & Hers: From Viral Ad to Volatile StockBy Jeffrey Neal Johnson | February 18, 2025View Hims & Hers: From Viral Ad to Volatile StockPGNY, HIMS, OPCH, and GH Company DescriptionsGuardant Health NASDAQ:GH$42.89 +2.25 (+5.54%) Closing price 03/14/2025 04:00 PM EasternExtended Trading$42.74 -0.16 (-0.36%) As of 03/14/2025 07:28 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Guardant Health, Inc., a precision oncology company, provides blood and tissue tests, data sets, and analytics in the United States and internationally. The company provides Guardant360; Guardant360 LDT; Guardant360 CDx Test; Guardant360 Response Test; Guardant360 TissueNext Test; GuardantINFINITY Test; GuardantConnect, an integrated software-based solution designed for clinical and biopharmaceutical customers to connect patients tested with assays with actionable alterations with potentially relevant clinical studies; GuardantOMNI Test for advanced stage cancer; and GuardantINFORM, an in-silico research platform for tumor evolution and treatment resistance across various biomarker-driven cancers. It offers Shield Test; Guardant Reveal Test for adjuvant treatment selection in early-stage cancer patients; Smart Liquid Biopsy Platform; and Guardant Galaxy, an AI-backed digital pathology platform that helps improve cancer biomarker detection. In addition, the company offers development services, including companion diagnostic development and regulatory approval, clinical study setup, monitoring and maintenance, testing development and support, technologies licensing, and kits fulfillment. The company has a collaboration agreement with Illumina, Inc. for the sharing of specimen samples to advance cancer research. The company was incorporated in 2011 and is headquartered in Palo Alto, California.Hims & Hers Health NYSE:HIMS$33.10 +1.56 (+4.96%) Closing price 03/14/2025 03:59 PM EasternExtended Trading$33.28 +0.17 (+0.52%) As of 03/14/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.Option Care Health NASDAQ:OPCH$32.66 +0.42 (+1.30%) Closing price 03/14/2025 04:00 PM EasternExtended Trading$32.43 -0.23 (-0.70%) As of 03/14/2025 05:30 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Option Care Health, Inc. offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders. It also offers treatments to manage the progression of neurological disorders, such as multiple sclerosis, duchenne muscular dystrophy, and other neurological disorder; infusion therapies for bleeding disorders, such as hemophilia and von Willebrand diseases; therapies for women with high-risk pregnancies; and other infusion therapies to treat various conditions, including pain management, chemotherapy, and respiratory medications, as well as nursing services. The company markets its services through patient referrals, including physicians, hospital discharge planners, hospital personnel, health maintenance organizations, and preferred provider organizations. Option Care Health, Inc. is headquartered in Bannockburn, Illinois.Progyny NASDAQ:PGNY$20.36 +0.52 (+2.62%) Closing price 03/14/2025 04:00 PM EasternExtended Trading$20.36 0.00 (0.00%) As of 03/14/2025 06:55 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides its members with access to the medications needed during their treatment. In addition, it provides assistance service programs where various services can be offered through a reimbursement program, including adoption, surrogacy, doula, and travel reimbursement when travel is required to receive medical services. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Rubrik Stock’s V-Bottom Reversal Signals a Major Rally Ahead How Super Micro Computer Stock Is Defying the Market Sell-Off Palantir’s Deal With Archer Aviation Keeps AI’s Future in Focus D-Wave Quantum Stock Jumps on "Quantum Supremacy" News Is a Bottom Finally Forming in Rocket Lab Stock? Intel Stock Surges on New CEO – The Real Story Runs Deeper AMD Stock: Can the PC Refresh Cycle Spark a Rally? Ramaco Resources Pins Hopes on Coal's Untapped Potential Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
